Breaking News Instant updates and real-time market news.

TODAY'S FREE FLY STORIES

Recommendations
Allianz price target raised to EUR 202 from EUR 195 at JPMorgan » 12:14
07/13/20
07/13
12:14
07/13/20
12:14
AZSEY

Allianz

$0.00 /

+ (+0.00%)

JPMorgan analyst Ashik…

JPMorgan analyst Ashik Musaddi raised the firm's price target on Allianz to EUR 202 from EUR 195 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
AZSEY Allianz
$0.00 /

+ (+0.00%)

06/15/20 RBC Capital
Allianz price target raised to EUR 165 from EUR 163 at RBC Capital
05/13/20 UBS
Allianz price target lowered to EUR 215 from EUR 235 at UBS
03/05/20 Berenberg
Allianz initiated with a Buy at Berenberg
12/04/19 Barclays
Allianz downgraded to Equal Weight from Overweight at Barclays
Periodicals
Southwest says passenger numbers need to triple to evade layoffs, Bloomberg says » 12:11
07/13/20
07/13
12:11
07/13/20
12:11
LUV

Southwest

$32.92 /

-0.28 (-0.84%)

Southwest Airlines CEO…

Southwest Airlines CEO Gary Kelly said the carrier will need to triple its passenger numbers by the end of the year if it wants to evade involuntary job cuts, Bloomberg's Mary Schlangenstein reports, citing the CEO. Kelly said the airline remains overstaffed for operations and workers have until Wednesday to apply for voluntary separation or extended time off to help decrease spending on labor. "The recent rise in Covid cases and increases in regional restrictions on businesses and states requiring quarantine aren't positive developments for our business," Kelly said. "We're very concerned about the impact on already weak travel demand." Reference Link

ShowHide Related Items >><<
LUV Southwest
$32.92 /

-0.28 (-0.84%)

LUV Southwest
$32.92 /

-0.28 (-0.84%)

07/13/20 Wolfe Research
Southwest downgraded to Peer Perform from Outperform at Wolfe Research
07/13/20 Deutsche Bank
Southwest price target raised to $48 from $44 at Deutsche Bank
07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20
Fly Intel: Top five analyst upgrades
LUV Southwest
$32.92 /

-0.28 (-0.84%)

  • 29
    Apr
LUV Southwest
$32.92 /

-0.28 (-0.84%)

LUV Southwest
$32.92 /

-0.28 (-0.84%)

LUV Southwest
$32.92 /

-0.28 (-0.84%)

Recommendations
Intrum Q2 pre-announcement better-than-expected, says UBS » 12:08
07/13/20
07/13
12:08
07/13/20
12:08
ITJTY

Intrum

$0.00 /

+ (+0.00%)

UBS analyst Johan Ekblom…

UBS analyst Johan Ekblom reiterated a Neutral rating and EUR135 price target on Intrum, saying that the company has pre-announced "significantly" better than expected Q2 results. Ekblom noted that the beat comes mainly from Strategic Markets.

ShowHide Related Items >><<
ITJTY Intrum
$0.00 /

+ (+0.00%)

05/13/20 UBS
Intrum price target lowered to SEK 135 from SEK 165 at UBS
03/31/20 JPMorgan
Intrum price target lowered to SEK 155 from SEK 295 at JPMorgan
Recommendations
G4S' DPA penalty resolves legacy contract overhang, says UBS » 12:07
07/13/20
07/13
12:07
07/13/20
12:07
GFSZY

G4S

$0.00 /

+ (+0.00%)

UBS analyst Rory McKenzie…

UBS analyst Rory McKenzie backed a Neutral rating and GBp 85 price target on G4S, saying that the penalty as part of a DPA is nearly twice Serco's settlement, but adds less than 0.1x to Net Debt/EBITDA and resolves a key legacy contract overhang.

ShowHide Related Items >><<
GFSZY G4S
$0.00 /

+ (+0.00%)

07/08/20 Deutsche Bank
G4S price target raised to 140 GBp from 120 GBp at Deutsche Bank
06/24/20 Jefferies
G4S price target raised to 140 GBp from 115 GBp at Jefferies
06/22/20 Credit Suisse
G4S upgraded to Outperform from Neutral at Credit Suisse
06/18/20 RBC Capital
G4S price target raised to 160 GBp from 130 GBp at RBC Capital
Options
Slack call volume above normal and directionally bullish » 12:05
07/13/20
07/13
12:05
07/13/20
12:05
WORK

Slack Technologies

$34.93 /

+1.09 (+3.22%)

Bullish option flow…

Bullish option flow detected in Slack with 107,054 calls trading, 3x expected, and implied vol increasing over 10 points to 72.02%. Jul-20 35 calls and Jul-20 38 calls are the most active options, with total volume in those strikes near 34,400 contracts. The Put/Call Ratio is 0.08. Earnings are expected on September 2nd.

ShowHide Related Items >><<
WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

06/24/20 Goldman Sachs
Slack Technologies price target raised to $31 from $30 at Goldman Sachs
06/19/20
Fly Intel: Top five analyst downgrades
06/19/20 Goldman Sachs
Slack Technologies downgraded to Sell from Neutral at Goldman Sachs
06/05/20
Fly Intel: Top five analyst downgrades
WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

WORK Slack Technologies
$34.93 /

+1.09 (+3.22%)

Recommendations
UBS backs Buy on BASF after Q2 EBIT higher than consensus » 12:04
07/13/20
07/13
12:04
07/13/20
12:04
BASFY

BASF

$0.00 /

+ (+0.00%)

UBS analyst Andrew Stott…

UBS analyst Andrew Stott backed a Neutral rating and EUR53 price target on BASF after the company's Q2 EBIT was higher than consensus.

ShowHide Related Items >><<
BASFY BASF
$0.00 /

+ (+0.00%)

BASFY BASF
$0.00 /

+ (+0.00%)

07/08/20 UBS
BASF price target raised to EUR 53 from EUR 47 at UBS
06/09/20 HSBC
BASF downgraded to Hold from Buy at HSBC
06/03/20 Pareto
BASF upgraded to Buy from Hold at Pareto
06/03/20 Jefferies
BASF upgraded to Buy from Hold at Jefferies
BASFY BASF
$0.00 /

+ (+0.00%)

BASFY BASF
$0.00 /

+ (+0.00%)

Recommendations
Savills price target lowered to 850 GBp from 1230 GBp at UBS » 12:03
07/13/20
07/13
12:03
07/13/20
12:03
SVLPF

Savills

$0.00 /

+ (+0.00%)

UBS analyst Osmaan Malik…

UBS analyst Osmaan Malik lowered the firm's price target on Savills to 850 GBp from 1230 GBp and keeps a Neutral rating on the shares.

Recommendations
UBS reiterates Buy on GSK as FDA belantamab docs are out » 12:02
07/13/20
07/13
12:02
07/13/20
12:02
GSK

GlaxoSmithKline

$40.32 /

+0.415 (+1.04%)

UBS analyst Laura…

UBS analyst Laura Sutcliffe reiterated a Buy rating and GBp 1,920 price target on GlaxoSmithKline, saying that, on schedule, FDA documents for the belantamab ad com are out.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

Hot Stocks
Studio City falls -11.7% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
MSC

Studio City

$13.95 /

-2.58 (-15.61%)

Studio City is down…

Studio City is down -11.7%, or -$1.84 to $13.95.

ShowHide Related Items >><<
MSC Studio City
$13.95 /

-2.58 (-15.61%)

MSC Studio City
$13.95 /

-2.58 (-15.61%)

Hot Stocks
GAMCO Investors falls -12.1% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
GBL

GAMCO Investors

$11.66 /

-1.22 (-9.47%)

GAMCO Investors is down…

GAMCO Investors is down -12.1%, or -$1.61 to $11.66.

ShowHide Related Items >><<
GBL GAMCO Investors
$11.66 /

-1.22 (-9.47%)

Hot Stocks
American Medical Laboratories Inc falls -40.2% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
AMJ

American Medical Laboratories Inc

$12.15 /

-0.33 (-2.64%)

American Medical…

American Medical Laboratories Inc is down -40.2%, or -$8.18 to $12.15.

ShowHide Related Items >><<
AMJ American Medical Laboratories Inc
$12.15 /

-0.33 (-2.64%)

Hot Stocks
Vivint Solar rises 12.5% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
VSLR

Vivint Solar

$17.98 /

+1.995 (+12.48%)

Vivint Solar is up 12.5%,…

Vivint Solar is up 12.5%, or $2.00 to $17.97.

ShowHide Related Items >><<
VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

07/13/20 KeyBanc
Vivint Solar price target raised to $18 from $12 at KeyBanc
07/13/20 KeyBanc
KeyBanc upgrades Sunrun to Overweight on Vivint merger
07/08/20 Roth Capital
Sunrun, Vivint combined entity results in substantial scale, says Roth Capital
07/08/20 Roth Capital
Vivint Solar acquisition by Sunrun could drive costs lower, says Roth Capital
VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

VSLR Vivint Solar
$17.98 /

+1.995 (+12.48%)

Hot Stocks
Herbalife Nutrition rises 14.5% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
HLF

Herbalife Nutrition

$52.37 /

+6.765 (+14.83%)

Herbalife Nutrition is up…

Herbalife Nutrition is up 14.5%, or $6.63 to $52.27.

ShowHide Related Items >><<
HLF Herbalife Nutrition
$52.37 /

+6.765 (+14.83%)

HLF Herbalife Nutrition
$52.37 /

+6.765 (+14.83%)

06/22/20 Citi
Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch'
05/08/20 Jefferies
Herbalife Nutrition price target raised to $45 from $40 at Jefferies
05/08/20 Citi
Herbalife Nutrition price target raised to $56 from $49 at Citi
12/04/19 Citi
Herbalife Nutrition assumed with a Buy at Citi
HLF Herbalife Nutrition
$52.37 /

+6.765 (+14.83%)

HLF Herbalife Nutrition
$52.37 /

+6.765 (+14.83%)

HLF Herbalife Nutrition
$52.37 /

+6.765 (+14.83%)

Hot Stocks
Laix rises 15.9% » 12:00
07/13/20
07/13
12:00
07/13/20
12:00
LAIX

Laix

$3.08 /

+0.38 (+14.07%)

Laix is up 15.9%, or 43c…

Laix is up 15.9%, or 43c to $3.13.

ShowHide Related Items >><<
LAIX Laix
$3.08 /

+0.38 (+14.07%)

LAIX Laix
$3.08 /

+0.38 (+14.07%)

06/04/20 Goldman Sachs
Laix upgraded to Neutral from Sell at Goldman Sachs
02/03/20 Goldman Sachs
Laix downgraded to Sell from Neutral at Goldman Sachs
01/10/20 Morgan Stanley
Laix downgraded to Underweight from Equal Weight at Morgan Stanley
09/06/19 Goldman Sachs
Laix downgraded to Neutral from Buy at Goldman Sachs
General news
Treasury's $105 B 3- and 6-month bill sales were mixed » 12:00
07/13/20
07/13
12:00
07/13/20
12:00

Treasury's $105 B 3-…

Treasury's $105 B 3- and 6-month bill sales were mixed with the shorter tranche underperforming. The volume of the package was left unchanged for a third week. It looks like the surge in risk appetite has taken some of the bid out of the bills. And though rates have cheapened somewhat today after rates dropped sharply late last week, they are still at relatively rich levels. The $54 B 3-month offering stopped on the screws at 0.145% after having cheapened fractionally to that level into the bid deadline. But it's marginally below the 0.150% last week and is the richest since May 26. There were $143.5 B in bids for a 2.68 cover, modestly better than the 2.66 previously, but slightly below the 2.88 average. Indirect bidders accepted 38.7%, fractionally less than last week's 39.8% and below the 45.8% average. It's the second weakest since the March 30 auction. The $51 B 6-month bill stopped at 0.145%, through the 0.155% at the deadline (where it traded most of the session). And it's 2 bps richer than last week's 0.165% award rate. It's also the richest award rate since May 4. Bids totaled $160.7 B for a 3.17 cover, stronger than the prior week's 2.81 as well as the 2.99 average. It's the best since April 27. Indirect bidders accepted 55.6%, also better than both last week's 42.2% and the 46.4% average. And it's the highest since April 6.

Recommendations
'Long-road back' for Shell to win back investor trust, says Citi » 11:59
07/13/20
07/13
11:59
07/13/20
11:59
RDS.A

Royal Dutch Shell

$32.66 /

+0.46 (+1.43%)

Citi analyst Alastair…

Citi analyst Alastair Syme reiterated a Sell rating and GBp 1,180 price target on Royal Dutch Shell, saying it looks like a "long-road back" for management to win back investor trust.

ShowHide Related Items >><<
RDS.A Royal Dutch Shell
$32.66 /

+0.46 (+1.43%)

RDS.A Royal Dutch Shell
$32.66 /

+0.46 (+1.43%)

06/15/20 UBS
Royal Dutch Shell price target raised to 1,750 GBp from 1,650 GBp at UBS
05/13/20 Redburn
Royal Dutch Shell upgraded to Neutral from Sell at Redburn
05/04/20 UBS
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at UBS
05/01/20 Citi
Citi cuts Royal Dutch Shell price target 11% to GBp 1180
RDS.A Royal Dutch Shell
$32.66 /

+0.46 (+1.43%)

RDS.A Royal Dutch Shell
$32.66 /

+0.46 (+1.43%)

RDS.A Royal Dutch Shell
$32.66 /

+0.46 (+1.43%)

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 11:59
07/13/20
07/13
11:59
07/13/20
11:59

Software & Internet…

Software & Internet Analyst Thill, along with Anurag Sarin, Senior Manager of Digital Finance Transformation at Deloitte, discuss back office apps and ERP transformations for the cloud space on an Analyst/Industry conference call to be held on July 14 at 11 am.

Recommendations
Strong 1H20 results expected for GVC, says Citi » 11:58
07/13/20
07/13
11:58
07/13/20
11:58
GMVHF

GVC Holdings

$0.00 /

+ (+0.00%)

Citi analyst Monique…

Citi analyst Monique Pollard reiterated a Buy rating and GBp 960 price target on GVC, saying that "strong" H1 results are expected. Pollard said that strong web visits data suggests outperformance by the company.

ShowHide Related Items >><<
GMVHF GVC Holdings
$0.00 /

+ (+0.00%)

GMVHF GVC Holdings
$0.00 /

+ (+0.00%)

07/08/20 Jefferies
GVC has 'credible' U.S. sports betting aspirations, says Jefferies
07/07/20 Deutsche Bank
GVC Holdings price target raised to 1,040 GBp from 930 GBp at Deutsche Bank
06/09/20 HSBC
GVC Holdings downgraded to Hold from Buy at HSBC
05/19/20 Morgan Stanley
GVC Holdings price target raised to 1,100 GBp from 1,000 GBp at Morgan Stanley
Recommendations
Carlsberg 'surprised the market' with H1 pre-announcement, says Citi » 11:56
07/13/20
07/13
11:56
07/13/20
11:56
CABGY

Carlsberg

$0.00 /

+ (+0.00%)

Citi analyst Simon Hales…

Citi analyst Simon Hales reiterated a Buy rating and DKK 1,030 price target on Carlsberg, saying the company "surprised the market" by pre-announcing its headline results for 1H20. Hales noted that volumes were better but price/mix was worse than expected.

ShowHide Related Items >><<
CABGY Carlsberg
$0.00 /

+ (+0.00%)

CABGY Carlsberg
$0.00 /

+ (+0.00%)

07/13/20 Morgan Stanley
Carlsberg price target raised to DKK 1,000 from DKK 955 at Morgan Stanley
07/09/20 UBS
Carlsberg price target raised to DKK 720 from DKK 660 at UBS
07/02/20 Barclays
Carlsberg price target raised to DKK 988 from DKK 923 at Barclays
06/08/20 JPMorgan
Carlsberg upgraded to Overweight from Neutral at JPMorgan
Recommendations
BT Group to feel 'strong' COVID-19 impact in Q1 report, says Citi » 11:55
07/13/20
07/13
11:55
07/13/20
11:55
BTGOF

BT Group

$0.00 /

+ (+0.00%)

Citi analyst Siyi He…

Citi analyst Siyi He reiterated a Neutral rating and GBp 110 price target on BT Group ahead of its Q1 earnings report. He said that the company will feel a "strong impact" from COVID-19 on its financial performance during this quarter.

ShowHide Related Items >><<
BTGOF BT Group
$0.00 /

+ (+0.00%)

06/25/20 BTIG
RingCentral price target raised to $325 from $275 at BTIG
05/27/20 Barclays
BT Group price target lowered to 115 GBp from 120 GBp at Barclays
05/15/20 Morgan Stanley
BT Group price target lowered to 125 GBp from 150 GBp at Morgan Stanley
05/05/20 JPMorgan
BT Group price target lowered to 182 GBp from 210 GBp at JPMorgan
Options
Intra Cellular Therapies put volume heavy and directionally bearish » 11:55
07/13/20
07/13
11:55
07/13/20
11:55
ITCI

Intra-Cellular

$24.53 /

-0.19 (-0.77%)

Bearish flow noted in…

Bearish flow noted in Intra Cellular Therapies with 1,296 puts trading, or 2x expected. Most active are Aug-20 15 puts and Aug-20 35 calls, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 1.89, while ATM IV is up nearly 4 points on the day. Earnings are expected on August 5th.

ShowHide Related Items >><<
ITCI Intra-Cellular
$24.53 /

-0.19 (-0.77%)

ITCI Intra-Cellular
$24.53 /

-0.19 (-0.77%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
ITCI Intra-Cellular
$24.53 /

-0.19 (-0.77%)

  • 08
    Jan
Recommendations
St. James's Place price target lowered to 958 GBp from 971 GBp at Morgan Stanley » 11:53
07/13/20
07/13
11:53
07/13/20
11:53
STJPF

St. James's Place

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Jon Hocking lowered the firm's price target on St. James's Place to 958 GBp from 971 GBp and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
STJPF St. James's Place
$0.00 /

+ (+0.00%)

06/25/20 UBS
St. James's Place price target raised to 965 GBp from 925 GBp at UBS
06/25/20 Berenberg
St. James's Place price target raised to 1,005 GBp from 875 GBp at Berenberg
06/24/20 Barclays
St. James's Place price target raised to 1,120 GBp from 1,118 GBp at Barclays
06/24/20 Deutsche Bank
St. James's Place price target raised to 1,020 GBp at Deutsche Bank
Recommendations
Wartsila price target lowered to EUR 7.80 from EUR 8.40 at Morgan Stanley » 11:53
07/13/20
07/13
11:53
07/13/20
11:53
WRTBY

Wartsila

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Robert Davies lowered the firm's price target on Wartsila to EUR 7.80 from EUR 8.40 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
WRTBY Wartsila
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
Wartsila price target lowered to EUR 7.10 from EUR 7.50 at JPMorgan
04/23/20 AlphaValue
Wartsila downgraded to Add from Buy at AlphaValue
04/22/20 Morgan Stanley
Wartsila price target lowered to EUR 8.40 from EUR 9.30 at Morgan Stanley
03/19/20 RBC Capital
Wartsila double-upgraded to Outperform from Underperform at RBC Capital
Recommendations
Melrose Industries price target lowered to 140 GBp from 145 GBp at Morgan Stanley » 11:52
07/13/20
07/13
11:52
07/13/20
11:52
MLSPF

Melrose Industries

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Robert Davies lowered the firm's price target on Melrose Industries to 140 GBp from 145 GBp and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
MLSPF Melrose Industries
$0.00 /

+ (+0.00%)

06/08/20 Stifel
Melrose Industries downgraded to Hold from Buy at Stifel
06/02/20 Morgan Stanley
Melrose Industries initiated with an Equal Weight at Morgan Stanley
04/26/20 Goldman Sachs
Melrose Industries downgraded to Neutral from Buy at Goldman Sachs
02/07/20 Goldman Sachs
Melrose Industries downgraded to Buy from Conviction Buy at Goldman Sachs
Conference/Events
UBS industrials analysts to hold an analyst/industry conference call » 11:51
07/13/20
07/13
11:51
07/13/20
11:51

Analysts, along with Bye…

Analysts, along with Bye Aerospace, discuss electric aviation on an Analyst/Industry conference call on an Analyst/Industry conference call to be held on July 15 at 11 am.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.